RNF25 was highly expressed in tumor tissues from clinical samples, and its knockdown significantly reduced the viability, proliferation, and migration of U266 cells, while promoting apoptosis.<h4>Conclusions</h4>RNF25 may serve as a potential prognostic biomarker for MM and holds promise as a candidate therapeutic target. Here, RNF25 is linked to Miyoshi myopathy.